Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-15-004114
Filing Date
2015-02-04
Accepted
2015-02-04 16:38:57
Documents
2
Period of Report
2015-02-02

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 1731
2 POWER OF ATTORNEY poa_benaim.htm EX-24 7161
  Complete submission text file 0001140361-15-004114.txt   10378
Mailing Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850 2402685300
REXAHN PHARMACEUTICALS, INC. (Issuer) CIK: 0001228627 (see all company filings)

EIN.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O REXAHN PHARMACEUTICALS, INC. 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850
Business Address
Benaim Ely (Reporting) CIK: 0001632237 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34079 | Film No.: 15575980